UK manufacturing begins to rebuild

UK manufacturing output rose in October for the first time in over a year, marking a shift that has largely gone unnoticed. The sector has spent much of the past 18 months under pressure, weighed down by weak demand, high input costs, and persistent uncertainty. But the latest signals suggest those conditions are beginning to ease. The official purchasing managers’ index moved to a twelve-month high of 44.8 in October, still below the 50 mark, but moving in the right direction and at its strongest level in a year.

More notably, the uptick in output was broad-based across several categories. Transport, machinery, and consumer goods producers all reported month-on-month increases. Manufacturers also cited early signs of improving orders, both at home and abroad, even if export volumes remain uneven. With inventories normalising and supply chain disruption largely resolved, many firms have shifted focus back to production, which has begun to feed into output data.

Confidence among manufacturers is also strengthening. Business expectations are now at their highest since early 2022, supported by better order visibility and a more stable input cost environment. Energy prices, which had been a major drag in the previous winter, have moderated, giving firms more breathing room on margins. With pricing power still limited, the relief on cost pressure is material and timely.

Likewise Group PLC (LON:LIKE) is a distributor of floorcoverings and matting and has the opportunity to consolidate the domestic and commercial floorcovering markets to become one of the UK’s largest distributors in this sector.

Share on:

Latest Company News

James Cropper: Better materials require better questions

James Cropper says better material choices start with understanding the full requirements of a product, from performance and design to sustainability and end-of-life considerations.

Can nuclear energy play a bigger role in the energy transition?

Nuclear power is being reassessed as countries seek reliable low-carbon electricity, with SMRs, financing, regulation and supply chains likely to determine how quickly new capacity can be deployed.

Why scientific breakthroughs are creating new opportunities

Biotech investment is being driven by medical demand, advances in drug development and pharmaceutical demand for new treatments, but company selection remains critical because clinical and regulatory risks are high.

EDX Medical expands employee health screening with wider disease testing

EDX Medical is expanding employee health screening with tests designed to identify hundreds of diseases from one or two samples, with three major UK employers expected to start programmes later in 2026.

Arbuthnot Commercial ABL provides growth funding to Cross + Morse

Arbuthnot Commercial ABL has provided growth funding to Cross + Morse, supporting the Birmingham manufacturer's expansion and Astwood Group's plans for further acquisitions.

Physitrack expands into AI-powered physical therapy practice management

Physitrack is expanding into AI-powered electronic medical records and practice management, combining clinical documentation, scheduling and patient management with its existing digital rehabilitation technology.

    Search